Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients

Parfrey, 1994, Long term cardiac morbidity and mortality during dialysis therapy, Adv Nephr, 23, 311

Churchill, 1993, Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients, Kidney Int, 43, S16

Ma, 1992, Cardiovascular risk factors in chronic renal failure and hemodialysis populations, Am J Kid Dis, 19, 505, 10.1016/S0272-6386(12)80827-4

Ueland, 1989, Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy, J Lab Clin Med, 114, 473

Selhub, 1993, Vitamin status and intake as primary determinants of homocysteinemia in an elderly population, J Am Med Assoc, 270, 2693, 10.1001/jama.270.22.2693

Mudd, 1975, Labile methyl balances for normal humans on various dietary regimens, Metabolism, 24, 721, 10.1016/0026-0495(75)90040-2

Brattstrom, 1994, Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects, J Intern Med, 236, 633, 10.1111/j.1365-2796.1994.tb00856.x

Bostom, 1995, Net uptake of plasma homocysteine by the rat kidney in vivo, Atherosclerosis, 116, 59, 10.1016/0021-9150(95)05522-X

Guttormsen, 1995, Elimination of homocysteine from plasma in subjects with endstage renal failure, Irish J Med Sci, 164, 8

Wilcken, 1979, Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide, Eur J Clin Invest, 9, 301, 10.1111/j.1365-2362.1979.tb00888.x

Wilcken, 1980, Accumulation of sulphur-containing amino acids including cysteine-homocysteine mixed disulfide in patients on maintenance haemodialysis, Clin Sci, 58, 427, 10.1042/cs0580427

Kang, 1983, Plasma protein-bound homocyst(e)ine in patients requiring chronic hemodialysis, Clin Sci, 65, 335, 10.1042/cs0650335

Smolin, 1987, Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis, Am J Clin Nutr, 45, 737, 10.1093/ajcn/45.4.737

Chauveau, 1993, Hyperhomocyst(e)inemia, a risk factor for atherosclerosis in chronic uremic patients, Kidney Int, 43, S72

Hultberg, 1993, Plasma homocysteine in renal failure, Clin Nephr, 40, 230

Stabler, 1993, Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency, Blood, 81, 3404, 10.1182/blood.V81.12.3404.3404

Perna, 1995, Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia, Kidney Int, 47, 247, 10.1038/ki.1995.31

Kim, 1994, Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients, Adv Perit Dial, 10, 282

Bostom, 1995, Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study, Atherosclerosis, 114, 93, 10.1016/0021-9150(94)05470-4

Bachmann, 1995, Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients, J Am Soc Nephrol, 6, 121, 10.1681/ASN.V61121

Boushey, 1995, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, J Am Med Assoc, 274, 1049, 10.1001/jama.274.13.1049

Frosst, 1995, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nature Genetics, 10, 111, 10.1038/ng0595-111

Jacques, 1996, Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations, Circulation, 93, 7, 10.1161/01.CIR.93.1.7

Bostom, 1995, Excess prevalence of hyperhomocysteinemia in dialysis dependent end-stage renal disease, Irish J Med Sci, 164, 3

McNamara, 1987, Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions, Clin Chim Acta, 166, 1, 10.1016/0009-8981(87)90188-4

Warnick, 1982, Dextran sulfate-magnesium precipitation procedure for quantitation of high density lipoprotein cholesterol, Clin Chem, 28, 1379, 10.1093/clinchem/28.6.1379

Owen, 1993, The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis, N Engl J Med, 329, 1001, 10.1056/NEJM199309303291404

Nolph, 1992, Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis, ASAIO J, 38, M139, 10.1097/00002480-199207000-00004

Araki, 1987, Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection, J Chromatogr, 422, 43, 10.1016/0378-4347(87)80438-3

Shin-Buering, 1981, A new enzymatic method for pyridoxal 5″-phosphate determination, J Inherit Metab Dis, 4, 123, 10.1007/BF02263621

Horne, 1988, Lactobacillus casei assay of folic acid derivatives in 96-well microtiter plates, Clin Chem, 34, 2357, 10.1093/clinchem/34.11.2357

1993, Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II), J Am Med Assoc, 269, 3015, 10.1001/jama.269.23.3015

1990

Brattstrom, 1988, Folic acid — an innocuous means to reduce plasma homocysteine, Scand J Clin Lab Invest, 48, 215, 10.3109/00365518809167487

Bostom, 1996, High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients, Kidney Int, 49, 147, 10.1038/ki.1996.19

Cressman, 1992, Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients, Circulation, 86, 475, 10.1161/01.CIR.86.2.475

Cressman, 1994, Lp(a) and premature mortality during chronic hemodialysis treatment, Chem Phys Lipids, 67/68, 419, 10.1016/0009-3084(94)90165-1

1995, Excerpts From The United States Renal Data System, United States Renal Data System 1995 Annual Report, Am J Kid Dis, 26, S1

Cupples, 1987, Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year follow-up

Ahmed, 1995, 30-day and 1-year mortality in hemodialysis patients undergoing coronary revascularization: results from a national cohort, Circulation, 92, I

1992, CANADA-USA (CANUSA) multicenter study of peritoneal dialysis adequacy: description of the study population and preliminary results. CANUSA Peritoneal Dilaysis Study Group, Adv Perit Dial, 8, 88